CXCL12 and breast cancer: Therefore, since SDF-1 is a key factor involved in the growth, angiogenesis, invasion, and metastasis of BC, pharmacologically targeting SDF-1 and its downstream signaling pathway could have a relevant therapeutic potential for BC.